Lexaria Bioscience Corp. Quarterly Comprehensive Income (Loss), Net of Tax, Attributable to Parent in USD from Q2 2011 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
-
Summary
-
Lexaria Bioscience Corp. quarterly/annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent history and growth rate from Q2 2011 to Q4 2024.
- Lexaria Bioscience Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the quarter ending November 30, 2024 was -$2.71M, a 130% decline year-over-year.
- Lexaria Bioscience Corp. Comprehensive Income (Loss), Net of Tax, Attributable to Parent for the twelve months ending November 30, 2024 was -$7.35M, a 20.8% decline year-over-year.
- Lexaria Bioscience Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2024 was -$5.82M, a 12.7% increase from 2023.
- Lexaria Bioscience Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2023 was -$6.66M.
- Lexaria Bioscience Corp. annual Comprehensive Income (Loss), Net of Tax, Attributable to Parent for 2018 was -$6.62M, a 243% decline from 2017.
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Trailing 12 Months (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Quarterly (USD)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, YoY Quarterly Growth (%)